Trials / Terminated
TerminatedNCT03256539
Napping, Sleep, Cognitive Decline and Risk of Alzheimer's Disease
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- University of California, San Francisco · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
This study aimed to pilot test a non-pharmacological (behavioral) treatment program targeting improved cognition through improving 24-h sleep-wake cycle in people with mild cognitive impairment (MCI) or mild Alzheimer's disease. A treatment program incorporating bright light therapy and a modified cognitive behavioral therapy for insomnia will be developed to address 24-hour patterns of sleep. We will then pilot test its feasibility and explore its preliminary effects on improving sleep/napping and cognition in patients with MCI or mild Alzheimer's disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Sleep intervention | Behavioral sleep intervention program |
| BEHAVIORAL | Placebo intervention | Quasi-desensitization intervention for insomnia (which does not include any of the active components of CBT-I but implemented in the same frequency and duration) |
Timeline
- Start date
- 2021-08-12
- Primary completion
- 2024-01-31
- Completion
- 2024-01-31
- First posted
- 2017-08-22
- Last updated
- 2025-11-14
- Results posted
- 2025-11-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03256539. Inclusion in this directory is not an endorsement.